JScopeJapan Capex

Menicon to add eight daily disposable contact lens production lines at its Malaysia factory

Pharma & MedicalKedah

MeniconMalaysia Sdn. Bhd. is investing in new production lines and molds at its factory in Kedah, Malaysia. The project will add eight production lines for daily disposable contact lenses, with completion scheduled for December 2027.

Company
Menicon Co., Ltd.
Investment
¥48.1B total
Location
Kedah
Capacity
8 daily disposable contact lens production lines
Announced
Jun 25, 2026
Ticker
7780
Phase
construction
Construction start
Aug 1, 2022
Completion
Dec 1, 2027
Want the full picture?See what you get

Olympus completes new B Building at Nagano site for medical-device component production

NewPharma & MedicalNaganoCompleted¥18B

Olympus has completed the new B Building at its Nagano site in Tatsuno, Nagano, consolidating development and manufacturing functions and establishing a production base for key medical-device components. Construction began in February 2025, with full operation targeted for FY2026; the building has 17,665 sqm of total floor area and a total construction cost of approximately ¥18 billion.

JGC completes Chugai Pharma's UT3 biopharmaceutical API facility in Utsunomiya

Pharma & MedicalTochigiCompleted

JGC Holdings completed the UT3 biopharmaceutical active pharmaceutical ingredient facility for Chugai Pharmaceutical Industry at its Utsunomiya plant in May 2026. The four-story facility supports clinical-trial manufacturing through initial commercial production and includes continuous-production capabilities, solar panels and other environmental features; it was handed over on May 14, 2026.

Lion to build new pharmaceutical plant in Hung Yen, Vietnam

Pharma & MedicalHung YenPlanned¥1.5B

Lion has approved construction of a new pharmaceutical plant through its wholly owned Vietnamese subsidiary Merap Lion. The facility will produce prescription and over-the-counter solid-dose medicines, including tablets and granules, with operations planned to begin in the second half of 2030.

Tsumura to build new quality-control facility to support stable supply

Pharma & MedicalIbarakiPlanned¥7B

Tsumura will build a new QC building and hazardous-materials warehouse at its Ibaraki Plant in Ami, Ibaraki, to strengthen quality-testing capacity and business continuity for its kampo pharmaceutical products. Construction costs approximately ¥7 billion, designed and built by Kajima Corporation, with completion planned for mid-April 2028.